An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
10 2019
Historique:
received: 08 07 2019
accepted: 02 09 2019
pubmed: 8 9 2019
medline: 29 8 2020
entrez: 8 9 2019
Statut: ppublish

Résumé

Cisplatin (CDDP) is one of the most important chemotherapeutic drugs in modern oncology. However, its use is limited by severe toxicities, which impair life quality after cancer. Here, we investigated the role of organic cation transporters (OCT) in mediating toxicities associated with chronic (twice the week for 4 weeks) low-dose (4 mg/kg body weight) CDDP treatment (resembling therapeutic protocols in patients) of wild-type (WT) mice and mice with OCT genetic deletion (OCT1/2

Identifiants

pubmed: 31493026
doi: 10.1007/s00204-019-02557-9
pii: 10.1007/s00204-019-02557-9
doi:

Substances chimiques

Antineoplastic Agents 0
Octamer Transcription Factor-1 0
Organic Cation Transporter 2 0
Pou2f1 protein, mouse 0
Slc22a2 protein, mouse 0
Cisplatin Q20Q21Q62J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2835-2848

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : 107/11-1
Pays : International
Organisme : NIH HHS
ID : R01CA215802
Pays : United States
Organisme : Fondazione Banca del Monte di Lombardia
ID : Paola Marmiroli
Pays : International
Organisme : NIH HHS
ID : R01CA215802
Pays : United States

Auteurs

Anna Hucke (A)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany.

Markus M Rinschen (MM)

Department II of Internal Medicine, and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Oliver B Bauer (OB)

Institut für Anorganische und Analytische Chemie, Westfälische Wilhelms-Universität, Münster, Germany.

Michael Sperling (M)

Institut für Anorganische und Analytische Chemie, Westfälische Wilhelms-Universität, Münster, Germany.

Uwe Karst (U)

Institut für Anorganische und Analytische Chemie, Westfälische Wilhelms-Universität, Münster, Germany.

Christina Köppen (C)

Institut für Anorganische und Analytische Chemie, Westfälische Wilhelms-Universität, Münster, Germany.

Karolin Sommer (K)

Institut für Anorganische und Analytische Chemie, Westfälische Wilhelms-Universität, Münster, Germany.

Rita Schröter (R)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany.

Cecilia Ceresa (C)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Alessia Chiorazzi (A)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Annalisa Canta (A)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Sara Semperboni (S)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Paola Marmiroli (P)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Guido Cavaletti (G)

Experimental Neurology Unit of the Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.

Stefan Schlatt (S)

Centrum für Reproduktionsmedizin und Andrologie, Universitätsklinikum Münster, Münster, Germany.

Eberhard Schlatter (E)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany.

Hermann Pavenstädt (H)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany.

Barbara Heitplatz (B)

Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Münster, Germany.

Veerle Van Marck (V)

Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster, Münster, Germany.

Alex Sparreboom (A)

Division of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.

Vivien Barz (V)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany.

Arne Knief (A)

Klinik für Phoniatrie und Pädaudiologie, Universitätsklinikum Münster, Münster, Germany.

Dirk Deuster (D)

Klinik für Phoniatrie und Pädaudiologie, Universitätsklinikum Münster, Münster, Germany.

Antoinette Am Zehnhoff-Dinnesen (AA)

Klinik für Phoniatrie und Pädaudiologie, Universitätsklinikum Münster, Münster, Germany.

Giuliano Ciarimboli (G)

Medizinische Klinik D, Experimentelle Nephrologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1/A14, 48149, Münster, Germany. gciari@uni-muenster.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH